BSR has published two updated guidelines with recommendations for using rheumatological drugs during conception, all stages of pregnancy, breastfeeding and in men who wish to conceive. The guidelines have been split into two parts covering:  prescribing medications to treat co-morbidities in rheumatic diseases during pregnancy and breastfeeding  prescribing immunomodulatory drugs during pregnancy and breastfeeding, including biologics and small molecule drugs  Join guideline working group chair, Professor Ian Giles, lead authors Dr Mark Russell and Dr Karen Shreiber, and lay member Clare Reid in a roundtable discussion hosted by Dr Marwan Bukhari. Read the full guidelines here.

The team from Chapel Allerton Hospital (Leeds, UK) join us to discuss their new giant cell arteritis referral pathway, which recently won a BSR Best Practice Award. Listen to Dr Thurkka Rajeswaran, Dr Sarah Mackie, Kate Smith and Borsha Sarker as they present their GCA pathway and results, reflect on MDT collaboration and advice for other units, and consider next steps.  You can read the team’s BSR Annual Conference abstract here: https://doi.org/10.1093/rheumatology/keac132.042 

We’re joined by Dr Anushka Soni, Sarah Manderson and Prof. Raashid Luqmani (Nuffield Orthopaedic Centre, Oxford) to discuss their remote clinical management pathway, which recently won a BSR Best Practice Award. The team talk us through their pathway, cost-savings, and the essential role of their admin team, before revealing their PIFU plans.  You can read the team’s BSR Annual Conference abstract here: https://doi.org/10.1093/rheumatology/keac133.114 The case study on NHX is here: https://www.nhsx.nhs.uk/key-tools-and-info/digital-playbooks/rheumatology-digital-playbook/Remote-clinical-management-as-part-of-standard-care-for-rheumatology-patients/ 

Dr Toby Garrood (Guy’s & St Thomas’, UK) joins us to discuss a three-part project to implement digital health in rheumatology, which recently won a BSR Best Practice Award. Toby talks us through the project, the process of developing patient personas to help test interventions, the benefits of a minimum viable product approach, and much more.

Co-leads Dr Laura Coates (Oxford, UK) and Dr William Tillett (Bath, UK) join us live from our Annual Conference to discuss the new 2022 BSR guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. This episode is hosted by Dr Marwan Bukhari. 

How will patients be affected by the 2022 BSR guideline on the management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy? Join junior doctor and IIM patient Dr Phoebe Rushe, Prof Hector Chinoy, Dr Alex Oldroyd, Dr James Lilleker and Dr Liza McCann in a roundtable discussion hosted by Dr Marwan Bukhari. Read the full guideline here: https://doi.org/10.1093/rheumatology/keac115

The 2022 BSR guideline on the management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy has been published, but what do you need to know? Join Prof Hector Chinoy, Dr Alex Oldroyd, Dr James Lilleker, Dr Liza McCann and Dr Phoebe Rushe in a roundtable discussion hosted by Dr Marwan Bukhari. Read the full guideline here: https://doi.org/10.1093/rheumatology/keac115

Clare Jacklin (NRAS, UK) and Dr James Galloway (KCL, UK) reflect on findings from the BSR National Early Inflammatory Arthritis Audit. They discuss the recent ethnicity report, the impact of the pandemic on data collection and rheumatology services, and the importance of patient participation and PROMs.Read the full ethnicity report here